vs
Side-by-side financial comparison of Dine Brands Global, Inc. (DIN) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Dine Brands Global, Inc. is the larger business by last-quarter revenue ($217.6M vs $168.4M, roughly 1.3× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 6.3%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 2.7%).
Dine Brands Global Inc. is a publicly traded food and beverage company based in Pasadena, California. Founded in 1958 as IHOP, it operates franchised and corporate owned full-service restaurants including three restaurant concepts, Applebee's Neighborhood Grill & Bar, International House of Pancakes (IHOP), and Fuzzy's Taco Shop.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
DIN vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $217.6M | $168.4M |
| Net Profit | $-12.2M | — |
| Gross Margin | 42.4% | — |
| Operating Margin | -7.6% | 50.6% |
| Net Margin | -5.6% | — |
| Revenue YoY | 6.3% | 143.7% |
| Net Profit YoY | -336.1% | — |
| EPS (diluted) | $-0.79 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $217.6M | $168.4M | ||
| Q3 25 | $216.2M | $87.3M | ||
| Q2 25 | $230.8M | $82.4M | ||
| Q1 25 | $214.8M | $65.0M | ||
| Q4 24 | $204.8M | $69.1M | ||
| Q3 24 | $195.0M | $51.6M | ||
| Q2 24 | $206.3M | $73.8M | ||
| Q1 24 | $206.2M | $137.7M |
| Q4 25 | $-12.2M | — | ||
| Q3 25 | $7.3M | $-31.3M | ||
| Q2 25 | $13.8M | $-12.7M | ||
| Q1 25 | $8.2M | $-40.5M | ||
| Q4 24 | $5.2M | — | ||
| Q3 24 | $19.1M | $-29.5M | ||
| Q2 24 | $23.2M | $-61.9M | ||
| Q1 24 | $17.5M | $61.0M |
| Q4 25 | 42.4% | — | ||
| Q3 25 | 39.1% | — | ||
| Q2 25 | 40.0% | — | ||
| Q1 25 | 42.0% | — | ||
| Q4 24 | 41.7% | — | ||
| Q3 24 | 47.8% | — | ||
| Q2 24 | 48.1% | — | ||
| Q1 24 | 47.2% | — |
| Q4 25 | -7.6% | 50.6% | ||
| Q3 25 | 4.7% | -11.4% | ||
| Q2 25 | 8.2% | 8.6% | ||
| Q1 25 | 6.0% | -34.0% | ||
| Q4 24 | 3.8% | -6.4% | ||
| Q3 24 | 13.6% | -31.0% | ||
| Q2 24 | 15.1% | 3.5% | ||
| Q1 24 | 11.7% | 52.5% |
| Q4 25 | -5.6% | — | ||
| Q3 25 | 3.4% | -35.9% | ||
| Q2 25 | 6.0% | -15.4% | ||
| Q1 25 | 3.8% | -62.2% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 9.8% | -57.2% | ||
| Q2 24 | 11.2% | -83.9% | ||
| Q1 24 | 8.5% | 44.3% |
| Q4 25 | $-0.79 | $0.32 | ||
| Q3 25 | $0.48 | $-0.16 | ||
| Q2 25 | $0.89 | $-0.06 | ||
| Q1 25 | $0.53 | $-0.21 | ||
| Q4 24 | $0.35 | $-0.14 | ||
| Q3 24 | $1.24 | $-0.15 | ||
| Q2 24 | $1.50 | $-0.33 | ||
| Q1 24 | $1.13 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.2M | $167.9M |
| Total DebtLower is stronger | $1.2B | — |
| Stockholders' EquityBook value | $-273.9M | $-302.0M |
| Total Assets | $1.7B | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.2M | $167.9M | ||
| Q3 25 | $167.9M | $92.4M | ||
| Q2 25 | $194.2M | $86.1M | ||
| Q1 25 | $186.5M | $114.6M | ||
| Q4 24 | $186.7M | $144.8M | ||
| Q3 24 | $169.6M | $144.7M | ||
| Q2 24 | $153.5M | $189.3M | ||
| Q1 24 | $145.0M | $226.6M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $-273.9M | $-302.0M | ||
| Q3 25 | $-231.9M | $-451.4M | ||
| Q2 25 | $-212.5M | $-433.5M | ||
| Q1 25 | $-215.7M | $-426.2M | ||
| Q4 24 | $-216.0M | $-388.7M | ||
| Q3 24 | $-216.7M | $-370.2M | ||
| Q2 24 | $-231.7M | $-344.2M | ||
| Q1 24 | $-244.8M | $-294.3M |
| Q4 25 | $1.7B | $465.9M | ||
| Q3 25 | $1.8B | $364.0M | ||
| Q2 25 | $1.8B | $347.1M | ||
| Q1 25 | $1.8B | $324.0M | ||
| Q4 24 | $1.8B | $343.8M | ||
| Q3 24 | $1.7B | $314.1M | ||
| Q2 24 | $1.7B | $352.3M | ||
| Q1 24 | $1.7B | $373.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | $45.2M |
| Free Cash FlowOCF − Capex | $-8.6M | — |
| FCF MarginFCF / Revenue | -3.9% | — |
| Capex IntensityCapex / Revenue | 6.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $53.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.7M | $45.2M | ||
| Q3 25 | $30.2M | $-4.3M | ||
| Q2 25 | $37.0M | $-31.4M | ||
| Q1 25 | $16.1M | $-22.6M | ||
| Q4 24 | $30.5M | $-35.0M | ||
| Q3 24 | $25.5M | $-35.3M | ||
| Q2 24 | $21.6M | $-7.2M | ||
| Q1 24 | $30.6M | $53.8M |
| Q4 25 | $-8.6M | — | ||
| Q3 25 | $18.1M | — | ||
| Q2 25 | $31.0M | — | ||
| Q1 25 | $12.8M | — | ||
| Q4 24 | $26.7M | — | ||
| Q3 24 | $22.0M | $-35.5M | ||
| Q2 24 | $18.2M | $-7.3M | ||
| Q1 24 | $27.2M | $53.8M |
| Q4 25 | -3.9% | — | ||
| Q3 25 | 8.4% | — | ||
| Q2 25 | 13.4% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | 13.0% | — | ||
| Q3 24 | 11.3% | -68.7% | ||
| Q2 24 | 8.8% | -9.9% | ||
| Q1 24 | 13.2% | 39.0% |
| Q4 25 | 6.6% | 0.0% | ||
| Q3 25 | 5.6% | 0.0% | ||
| Q2 25 | 2.6% | 0.0% | ||
| Q1 25 | 1.5% | 0.0% | ||
| Q4 24 | 1.9% | 0.0% | ||
| Q3 24 | 1.8% | 0.3% | ||
| Q2 24 | 1.7% | 0.1% | ||
| Q1 24 | 1.6% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 4.12× | — | ||
| Q2 25 | 2.68× | — | ||
| Q1 25 | 1.97× | — | ||
| Q4 24 | 5.88× | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 1.75× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIN
| Franchisor | $163.2M | 75% |
| Food And Beverage | $27.3M | 13% |
| Proprietary Product Sales And Other | $17.0M | 8% |
| Other | $8.1M | 4% |
| Franchise And Development Fees | $2.0M | 1% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
